Flemington, NJ, United States of America

Matthew Lombardo


 

Average Co-Inventor Count = 15.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Matthew Lombardo: Innovator in Pharmaceutical Compounds

Introduction

Matthew Lombardo is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions. With a total of 5 patents to his name, Lombardo's work is recognized for its potential impact on various disease states.

Latest Patents

Lombardo's latest patents include innovative compounds aimed at treating serious health issues. One of his key inventions is related to plasma kallikrein inhibitors. This invention provides a compound of Formula (I) and pharmaceutical compositions that can be used to treat or prevent conditions such as hereditary angioedema, uveitis, and diabetic retinopathy. The compounds developed are selective inhibitors of plasma kallikrein, showcasing their targeted therapeutic potential.

Another significant patent focuses on Factor XI activation inhibitors. This invention also presents a compound of Formula (I) and pharmaceutical compositions designed to treat or prevent thromboses, embolisms, and hypercoagulability. The compounds are selective Factor XI activation inhibitors, further demonstrating Lombardo's commitment to advancing medical treatments.

Career Highlights

Matthew Lombardo is currently associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company. His work at Merck has allowed him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.

Collaborations

Some of Lombardo's notable coworkers include Jacqueline D Hicks and Hong Dong Chu. Their collaborative efforts have likely played a role in the successful development of his patented inventions.

Conclusion

Matthew Lombardo's contributions to pharmaceutical innovations highlight his expertise and dedication to improving healthcare outcomes. His patents reflect a commitment to addressing critical medical challenges through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…